Impact of Latent Tuberculosis on Diabetes
ContributorsTepekule, Burcu
; Kusejko, Katharina; Zeeb, Marius; Tarr, Philip E; Calmy, Alexandra
; Battegay, Manuel; Furrer, Hansjakob; Cavassini, Matthias
; Bernasconi, Enos; Notter, Julia; Günthard, Huldrych F; Nemeth, Johannes; Kouyos, Roger D; Swiss HIV Cohort Study
Published inThe Journal of infectious diseases, vol. 225, no. 12, p. 2229-2234
Publication date2022-06-15
First online date2022-02-16
Abstract
Keywords
- Heterologous immunity
- Inflammatory diseases
- Innate immunity
- Latent Tuberculosis
- Low-grade inflammation
- Type-2 Diabetes Mellitus
Affiliation entities
Research groups
Funding
- Swiss National Science Foundation - Swiss HIV Cohort Study (SHCS) [33CS30_177499]
- Swiss National Science Foundation - Swiss HIV Cohort Study [33CS30_201369]
- Swiss National Science Foundation - HIV-1 Transmission in Switzerland: viral transmission traits, superinfection and drug resistance [324730B_179571]
- Swiss National Science Foundation - Using transmission networks for assessing and guiding prevention efforts in hiv [BSSGI0_155851]
- Swiss National Science Foundation - Exploring the role of myeloid cells in persisting Mycobacterium tuberculosis infection in vitro and in vivo [310030_200407]
Citation (ISO format)
TEPEKULE, Burcu et al. Impact of Latent Tuberculosis on Diabetes. In: The Journal of infectious diseases, 2022, vol. 225, n° 12, p. 2229–2234. doi: 10.1093/infdis/jiac054
Main files (1)
Article (Published version)
Secondary files (1)
Appendix
Identifiers
- PID : unige:161561
- DOI : 10.1093/infdis/jiac054
- PMID : 35172332
Additional URL for this publicationhttps://academic.oup.com/jid/article/225/12/2229/6529706
Journal ISSN0022-1899
